Refractory hepatic encephalopathy in a patient with hypothyroidism: Another element in ammonia metabolism

Autor: Rafael Bañares-Cañizares, Arantxa Díaz-Gómez, Luis Ibáñez-Samaniego, Juan A Guzmán-De-Villoria, Rita García-Martínez, Pilar Fernández-García, Marta Castillo-Pradillo, Fernando Diaz-Fontenla, Pilar Gancedo

Publikováno v: World Journal of Gastroenterology
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

Hepatic encephalopathy (HE) remains a diagnosis of exclusion due to the lack of specific signs and symptoms. Refractory HE is an uncommon but serious condition that requires the search of hidden precipitating events (i.e., portosystemic shunt) and al

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e5d6445de4ed6cc2cf55367ec53c4ef
http://europepmc.org/articles/PMC5537191

Influence of baseline MELD score in the efficacy of treatment of hepatitis C with simeprevir and sofosbuvir

Autor: Juan José Sánchez-Ruano, Elisa Martínez-Alfaro, Pilar Gancedo-Bringas, Emilia Tébar-Romero, Juan Ramón Larrubia-Marfil, José María Moreno-Planas, María del Mar Vicente-Gutiérrez, Roberto Patón-Arenas, Julia Morillas-Ariño, Mario Solera-Muñoz, Rosa María Sáiz-Chumillas, Alfredo Lucendo-Villarín

Publikováno v: Enfermedades infecciosas y microbiologia clinica (English ed.). 36(5)

There are few published studies on predictors of response to treatment with sofosbuvir and simeprevir in HCV patients.The objective of the study was to analyse possible predictors of response to simeprevir (SMV) and sofosbuvir (SOF) in patients infec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffc0652fdc096454da086b7096c45986
https://pubmed.ncbi.nlm.nih.gov/28641865

Abstracts Submitted for the 69th Annual Scientific Meeting of the American College of Gastroenterology.

Publikováno v: American Journal of Gastroenterology (Springer Nature); Oct2004 Supplement 1, Vol. 99, pS1-S335, 335p